33.25p-0.25 (-0.75%)21 Jun 2024, 16:28
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Creo Medical Group PLC Fundamentals

Company NameCreo Medical Group PLCLast Updated2024-06-21
IndustryMedical DevicesSectorHealthcare
Shares in Issue361.476 mMarket Cap£120.19 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.07EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1084Debt Equity Ratio0.0870
Asset Equity Ratio1.2809Cash Equity Ratio0.3094
Quick Ratio2.6667Current Ratio3.83
Price To Book Value2.0101ROCE0

Creo Medical Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Creo Medical Group PLC Company Financials

Tangible Assets£9.10 m£10.20 m£8.60 m
Intangible Assets£26.20 m£27.60 m£35.95 m
Investments£2.10 m£2.10 m£1.73 m
Total Fixed Assets£38.70 m£41.60 m£39.44 m
Stocks£8.10 m£9.30 m£8.50 m
Debtors£7.90 m£5.60 m£4.46 m
Cash & Equivalents£18.50 m£13.10 m£43.53 m
Other Assets£1.30 m£1.70 m-£6.84 m
Total Assets£76.60 m£75.20 m£100.61 m
Creditors within 1 year£9.90 m£17.40 m£19.74 m
Creditors after 1 year£6.90 m£8.50 m£7.55 m
Other Liabilities000
Total Liabilities£16.80 m£25.90 m£27.29 m
Net assets£59.80 m£49.30 m£73.32 m
Called up share capital£400,000.00£200,000.00£181,000.00
Share Premium£180.90 m£149.50 m£149.45 m
Profit / Loss-£24.50 m-£30.90 m-£30.34 m
Other Equity£59.80 m£49.30 m£73.32 m
Preference & Minorities000
Total Capital Employed£59.80 m£49.30 m£73.32 m
Debt Ratio£0.08£0.11£0.07
Assets / Equity1.28091.28091.2809
Cash / Equity0.30940.30940.3094
Cash Flow202320222021
Cash from operating activities-£21.60 m-£24.90 m-£26.01 m
Cashflow before financing£8.20 m-£24.50 m£5.98 m
Increase in Cash-£10.10 m-£30.50 m-£1.86 m
Turnover£30.80 m£27.20 m£25.16 m
Cost of sales£15.50 m£14.00 m£13.58 m
Gross Profit£15.30 m£13.20 m£11.59 m
Operating Profit-£24.80 m-£30.70 m-£29.91 m
Pre-Tax profit-£24.50 m-£30.90 m-£30.34 m

Creo Medical Group PLC Company Background

ActivitiesCreo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.
Latest Interim Date12 Sep 2023
Latest Fiscal Year End Date15 May 2024

Creo Medical Group PLC Directors

2024-05-21Mr. John BradshawNon-Executive Director,Senior Independent Non-Executive Director
2024-05-21Mr. Charles Alexander Evan SpicerNon-Executive Director,Chairman
2024-03-11Mr. Craig Jonathan GullifordExecutive Director,Chief Executive Officer
2024-03-11Mr. Richard John ReesExecutive Director,Chief Financial Officer and Company Secretary
2024-03-11Professor Christopher Paul HancockExecutive Director,Chief Technology Officer
2024-05-21Mr. David Gerard WoodsExecutive Director,Chief Commercial Officer
2024-05-21Ms. Ivonne Maria Gloria CantuNon-Executive Director

Creo Medical Group PLC Contact Details

Company NameCreo Medical Group PLC
AddressBeaufort Park Way, Unit 2, Creo House, Chepstow, NP16 5UH
Telephone+44 1291606005

Creo Medical Group PLC Advisors

SolicitorTaylor Wessing LLP
Phone+44 2073007000
Fax+44 2073007100
RegistrarEquiniti Limited
Phone+44 3713842030
Fax+44 3713842100
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
StockbrokerCenkos Securities
Phone+44 2073978900
Fax+44 2073978901
Nominated AdviserCenkos Securities
Phone+44 2073978900
Fax+44 2073978901